|
MGEA5 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 3.99099642223177E-11 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
5.64220000054405E-07 |
| Normal-vs-Stage2 |
6.336800E-03 |
| Normal-vs-Stage3 |
1.483850E-01 |
| Normal-vs-Stage4 |
1.448210E-01 |
| Stage1-vs-Stage2 |
5.859800E-01 |
| Stage1-vs-Stage3 |
5.768000E-02 |
| Stage1-vs-Stage4 |
1.345820E-01 |
| Stage2-vs-Stage3 |
6.890000E-02 |
| Stage2-vs-Stage4 |
1.271200E-01 |
| Stage3-vs-Stage4 |
8.784600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.00190000740241E-09 |
| Normal-vs-AfricanAmerican |
1.568590E-04 |
| Normal-vs-Asian |
3.809600E-01 |
| Caucasian-vs-AfricanAmerican |
6.287400E-01 |
| Caucasian-vs-Asian |
9.258400E-01 |
| AfricanAmerican-vs-Asian |
8.269600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
2.20059970246211E-10 |
| Normal-vs-Female |
7.9580000000079E-05 |
| Male-vs-Female |
7.062000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
1.526110E-02 |
| Normal-vs-Extreme_Weight |
1.377550E-04 |
| Normal-vs-Obese |
1.72437999998998E-05 |
| Normal-vs-Extreme_Obese |
1.393230E-01 |
| Normal_Weight-vs-Extreme_Weight |
5.903200E-01 |
| Normal_Weight-vs-Obese |
2.267600E-01 |
| Normal_Weight-vs-Extreme_Obese |
8.236400E-01 |
| Extreme_Weight-vs-Obese |
4.274000E-01 |
| Extreme_Weight-vs-Extreme_Obese |
9.362200E-01 |
| Obese-vs-Extreme_Obese |
6.235800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.174200E-02 |
| Normal-vs-Age(41-60Yrs) |
1.536899496557E-10 |
| Normal-vs-Age(61-80Yrs) |
3.14509999999046E-06 |
| Normal-vs-Age(81-100Yrs) |
4.284400E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
9.152400E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
5.656200E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
2.378000E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
1.387210E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
9.990300E-02 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
3.952200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
1.62447832963153E-12 |
| Normal-VS-Type2 PRCC |
9.369400E-01 |
| Normal-VS-KIRP CIMP |
2.914200E-02 |
| Normal-VS-Unclassified PRCC |
1.067870E-02 |
| Type1 PRCC-VS-Type2 PRCC |
1.6894263765721E-12 |
| Type1 PRCC-VS-KIRP CIMP |
3.196100E-03 |
| Type1 PRCC-VS-Unclassified PRCC |
8.226200E-02 |
| Type2 PRCC-VS-KIRP CIMP |
1.729370E-01 |
| Type2 PRCC-VS-Unclassified PRCC |
1.201800E-02 |
| KIRP CIMP-VS-Unclassified PRCC |
3.007000E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
7.524400E-03 |
| Normal-vs-N1 |
8.918200E-03 |
| Normal-vs-N2 |
7.825200E-01 |
| N0-vs-N1 |
9.122600E-01 |
| N0-vs-N2 |
4.708600E-01 |
| N1-vs-N2 |
3.101000E-01 |
|
|
